immunochemotherapy


Also found in: Dictionary.

immunochemotherapy

 [im″u-no-ke″mo-ther´ah-pe]
a combination of immunotherapy and chemotherapy.
Miller-Keane Encyclopedia and Dictionary of Medicine, Nursing, and Allied Health, Seventh Edition. © 2003 by Saunders, an imprint of Elsevier, Inc. All rights reserved.
Mentioned in ?
References in periodicals archive ?
Thereafter, we started immunochemotherapy by removing vincristine from the CHOP regimen due to concerns about adverse effects on the gastrointestinal system (e.g., paralytic ileus), which might exacerbate perforation.
The patient required 8 courses of immunochemotherapy (rituximab-cyclophosphamide, epirubicin, vincristine, and prednisone) and achieved complete remission [10] (see Table 1).
The woman had no history of preexisting neurologic disease or recent travel, but she had had follicular non-Hodgkin B-cell lymphoma since 2011, which evolved into a diffuse large B-cell lymphoma despite immunochemotherapy and corticosteroid treatment.
Arico et al., "Treatment of hemophagocytic lymphohistiocytosis with HLH-94 immunochemotherapy and bone marrow transplantation," Blood, vol.
Baia et al., "MYCIG rearrangements are negative predictors of survival in DLBCL patients treated with immunochemotherapy: a GELA/LYSA study," Blood, vol.
Park et al., "CD99 expression and newly diagnosed diffuse large B-cell lymphoma treated with rituximab-CHOP immunochemotherapy," Annals of Hematology, vol.
Ohira et al., "Correlation between efficacy of PSK postoperative adjuvant immunochemotherapy for gastric cancer and expression of MHC class I," Experimental & Therapeutic Medicine, vol.
Zembala, "Efficiency of adjuvant immunochemotherapy following curative resection in patients with locally advanced gastric cancer," Gastric Cancer, vol.
[49.] Hasselblom S, Hansson U, Olsson M (2010) High immunohistochemical expression of p-AKT predicts inferior survival in patients with diffuse large B-cell lymphoma treated with immunochemotherapy. Br J Haematol 149: 560-568.
(4) It appears that the prognosis of PB-DLBCL is generally comparable with that of nodal DLBCL and that standard treatment should consist of immunochemotherapy with an anthracycline-based regimen and include consolidation with radiotherapy especially in stage IE patients.
Kunii et al., "Randomized controlled trial of the efficacy of adjuvant immunochemotherapy and adjuvant chemotherapy for colorectal cancer, using different combinations of the intracutaneous streptococcal preparation OK-432 and the oral pyrimidines 1-hexylcarbamoyl-5-fluorouracil and uracil/tegafur," International Journal of Clinical Oncology, vol.